This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe
Data supporting the positive decision demonstrated that patients treated with Alluzience® for wrinkles had a rapid onset of effect starting from day one, with improvements lasting up to six months.1